Insider Transactions in Q3 2020 at Nkarta, Inc. (NKTX)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 14
2020
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
555,555
+16.59%
|
$9,999,990
$18.0 P/Share
|
|
Jul 14
2020
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,238,310
+50.0%
|
-
|
|
Jul 14
2020
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
3,333,333
+37.29%
|
$59,999,994
$18.0 P/Share
|
|
Jul 14
2020
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
2,271,796
+50.0%
|
-
|
|
Jul 14
2020
|
Glaxosmithkline PLC Director |
BUY
Open market or private purchase
|
Indirect |
833,333
+20.92%
|
$14,999,994
$18.0 P/Share
|
|
Jul 14
2020
|
Glaxosmithkline PLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,317,399
+46.33%
|
-
|
|
Jul 14
2020
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+29.24%
|
$18,000,000
$18.0 P/Share
|
|
Jul 14
2020
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,419,872
+50.0%
|
-
|